Effects of ALZ-801, an Oral Amyloid Oligomer Inhibitor, on Biomarkers of Alzheimer's Disease (AD): 12-Month Results of Phase 2 Biomarker Study in Early ADJohn Hey,Susan Abushakra,Kaj Blennow,Philip Scheltens,Jakub Hort,Katerina Sheardova,Niels Prins, Sterre Rutgers,Paul Dautzenberg,Ladislav Pazdera,Patrick Kesslak,Rosalind Mandelbaum,Aidan Power,Martin TolarNEUROLOGY（2023）引用 0|浏览27暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
